Item

Examining the impact of tislelizumab added to chemotherapy on health-related quality of life (HRQOL) outcomes in patients with advanced or metastatic esophageal squamous cell carcinoma (ESCC): the rationale-306 study

Xu, J.
; 
Jiménez-Fonseca, P.
; 
Kato, K.
; 
Shu, Y.
; 
Park, S. R.
; 
Hubner, R.
; 
Raymond, E.
; 
Yoon, H. H.
; 
Yan, S.
; 
Barnes, B.
... show 2 more
Citations
Altmetric:
Abstract
Authors
Xu, J.
Jiménez-Fonseca, P.
Kato, K.
Shu, Y.
Park, S. R.
Hubner, R.
Raymond, E.
Yoon, H. H.
Yan, S.
Barnes, B.
Mardiguian, S.
Barnes, G.
Affiliation
Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Beijing, Peoples R China Hosp Univ Cent Asturias, Oviedo, Asturias, Spain Natl Canc Ctr, Tokyo, Tokyo, Japan Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Peoples R China Univ Ulsan, Asan Med Ctr, Coll Med, Seoul, South Korea Univ Manchester, Christie NHS Fdn Trust, Dept Med Oncol, Div Canc Sci, Manchester, England Ctr Hosp Paris St Joseph, Paris, France Mayo Clin, Rochester, MN USA BeiGene USA Inc, San Mateo, CA USA BeiGene UK Ltd, London, England
Description
Date
2024
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Xu J, Jiménez-Fonseca P, Kato K, Shu Y, Park SR, Hubner R, et al. EXAMINING THE IMPACT OF TISLELIZUMAB ADDED TO CHEMOTHERAPY ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) OUTCOMES IN PATIENTS WITH ADVANCED OR METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC): THE RATIONALE-306 STUDY. VALUE IN HEALTH. 2024 DEC;27(12). PubMed PMID: WOS:001457338600018. English.
Journal Title
Journal ISSN
Volume Title
URI
https://christie.openrepository.com/handle/10541/627728
Embedded videos